X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Biocon Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON
Mar-18
ADCOCK INGRAM
Jun-14
BIOCON /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,188360-   
Low Rs305260-   
Sales per share (Unadj.) Rs68.7107.2-  
Earnings per share (Unadj.) Rs7.6-27.0-  
Cash flow per share (Unadj.) Rs14.0-22.4-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.384.1-  
Shares outstanding (eoy) m600.00168.78-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.92.9 375.4%   
Avg P/E ratio x98.9-11.5 -860.9%  
P/CF ratio (eoy) x53.4-13.9 -385.7%  
Price / Book Value ratio x8.63.7 234.5%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,90052,343 855.7%   
No. of employees `0006.14.3 143.2%   
Total wages/salary Rs m9,3113,285 283.4%   
Avg. sales/employee Rs Th6,705.84,214.0 159.1%   
Avg. wages/employee Rs Th1,514.2765.2 197.9%   
Avg. net profit/employee Rs Th736.9-1,061.8 -69.4%   
INCOME DATA
Net Sales Rs m41,23418,091 227.9%  
Other income Rs m2,062127 1,627.7%   
Total revenues Rs m43,29618,217 237.7%   
Gross profit Rs m8,291-3,135 -264.5%  
Depreciation Rs m3,851781 493.2%   
Interest Rs m615490 125.5%   
Profit before tax Rs m5,887-4,279 -137.6%   
Minority Interest Rs m213-12 -1,785.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569267 586.8%   
Profit after tax Rs m4,531-4,558 -99.4%  
Gross profit margin %20.1-17.3 -116.0%  
Effective tax rate %26.7-6.2 -426.5%   
Net profit margin %11.0-25.2 -43.6%  
BALANCE SHEET DATA
Current assets Rs m41,48613,250 313.1%   
Current liabilities Rs m21,4137,455 287.2%   
Net working cap to sales %48.732.0 152.0%  
Current ratio x1.91.8 109.0%  
Inventory Days Days64111 57.7%  
Debtors Days Days94124 76.0%  
Net fixed assets Rs m50,6617,723 655.9%   
Share capital Rs m3,00084 3,571.7%   
"Free" reserves Rs m48,8080-   
Net worth Rs m51,80814,199 364.9%   
Long term debt Rs m17,8984,990 358.7%   
Total assets Rs m99,89726,824 372.4%  
Interest coverage x10.6-7.7 -136.7%   
Debt to equity ratio x0.30.4 98.3%  
Sales to assets ratio x0.40.7 61.2%   
Return on assets %5.2-15.2 -34.0%  
Return on equity %8.7-32.1 -27.2%  
Return on capital %9.6-19.8 -48.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,7100-   
CASH FLOW
From Operations Rs m6,6211,544 428.8%  
From Investments Rs m-6,840-474 1,442.6%  
From Financial Activity Rs m-2,3974,529 -52.9%  
Net Cashflow Rs m-2,6125,599 -46.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.97 Rs / ZAR

Compare BIOCON With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: VENUS REMEDIES  PLETHICO PHARMA  PIRAMAL ENTERPRISES  SUN PHARMA  DR. DATSONS LABS  



Today's Market

Sensex Ends 135 Points Lower; Realty and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

A 90% Chance of Auto Stocks Moving Up This April(Profit Hunter)

Apr 5, 2019

The Auto index ended on a positive note in the month of April in 9 out of last 10 years. This Auto stock is best placed to benefit from the upswing in this sector.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 18, 2019 03:37 PM

TRACK BIOCON

BIOCON - PLETHICO PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS